respiratory
COPD

Four reasons behind the debate on ICS in COPD

Sponsored by A. Menarini Australia Pty Ltd

In a talk during a breakfast session at the TSANZSRS conference last week GOLD committee member Professor Alvar Agusti from Barcelona gave delegates his thoughts on why the debate around the use of inhaled corticosteroids in COPD continues despite clear guidelines.  Why the debate? There is a lot of debate about the position of inhaled ...

Already a member?

Enter your email to keep reading.


OR